Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil in Dementia Associated With Cerebrovascular Disease
NCT02660983Phase 4Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Aug 2013
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of donepezil in vascular dementia (3 arms), sponsored by Eisai Co., Ltd. Primary endpoints: Alzheimer's Disease Assessment Scale-Cognitive Subscale at 24 weeks and Clinician's Interview-Based Impression of Change-plus Caregiver Input at 24 weeks. Started Aug 2013; status: completed.
02
Drugs
donepezil
03
Conditions
vascular dementia
Beyond the preview
Go deeper on NCT02660983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02660983.